Delray Medical Center Becomes First Hospital in Florida to Use New Technology for Stroke Patients

Delray Medical Center is the first hospital in the state of Florida to use the RED 62™ Reperfusion Catheter & BENCHMARK BMX96™ for stroke patients.  Neurointerventionalist, Dr. Dennys Reyes, is the first doctor in the county to use this technology.

The RED 62™ is designed to navigate complex distal vessel anatomy and deliver powerful aspiration along with the BENCHMARK BMX96™ to remove blood clots in acute ischemic stroke patients with large vessel occlusions. In addition, it provides faster navigation and shorter times to recanalize “brain vessels”.

“The RED 62™ is engineered with some of the latest innovations in tracking and aspiration technology to address large vessel blockages from a stroke located in more challenging areas, while maximizing powerful aspiration to remove blood clots,” said Dr. Reyes.  “With the help of the BENCHMARK BMX96™ Access System, hypotube technology provides a higher stability for more complex cases when it comes to treatment of a stroke.  In addition, when performing a procedure, the catheter is designed to increase versatility and visualization designed to help offer patients the best possible outcomes.”

As a comprehensive stroke center, Delray Medical Center has advanced technology and services to help with any neurological issues.  Our hospital is a member of the Advanced Neuroscience Network, and integrated delivery system of medical professionals and hospitals focused on offering a full continuum of neurological care throughout South Florida.

“This new technology gives patients who come to our hospital for stroke care the latest in neurologic care,” said Maggie Gill, chief executive officer of the Palm Beach Health Network & Delray Medical Center.  “This hospital continues to be at the forefront when it comes to the newest medical care in our community, and the RED 62™ Reperfusion Catheter & BENCHMARK BMX96™ is no exception.”

For more information about our neurosciences program, go to www.delraymedicalctr.com or call 561-498-4440.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.